Literature DB >> 31701955

Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) †.

Dr M Dawar, Ms T Harris, Dr S McNeil.   

Abstract

Entities:  

Year:  2012        PMID： 31701955      PMCID： PMC6802461          DOI： 10.14745/ccdr.v38i00a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  111 in total

1.  HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

Authors:  Elmar A Joura; Susanne K Kjaer; Cosette M Wheeler; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricia García; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Matti Lehtinen; Marc Steben; Xavier Bosch; Joakim Dillner; Robert J Kurman; Slawomir Majewski; Nubia Muñoz; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine Bryan; Lisa C Lupinacci; Katherine E D Giacoletti; Shuang Lu; Scott Vuocolo; Teresa M Hesley; Richard M Haupt; Eliav Barr
Journal:  Vaccine       Date:  2008-10-16       Impact factor: 3.641

2.  Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.

Authors:  Sandra L Giannini; Emmanuel Hanon; Philippe Moris; Marcelle Van Mechelen; Sandra Morel; Francis Dessy; Marc A Fourneau; Brigitte Colau; Joann Suzich; Genevieve Losonksy; Marie-Thérèse Martin; Gary Dubin; Martine A Wettendorff
Journal:  Vaccine       Date:  2006-06-19       Impact factor: 3.641

Review 3.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

4.  Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States.

Authors:  Jill E Koshiol; Samantha A Laurent; Jeanne M Pimenta
Journal:  Sex Transm Dis       Date:  2004-12       Impact factor: 2.830

5.  Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Authors:  Nubia Muñoz; Susanne K Kjaer; Kristján Sigurdsson; Ole-Erik Iversen; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Darron R Brown; Laura A Koutsky; Eng Hseon Tay; Patricía J Garcia; Kevin A Ault; Suzanne M Garland; Sepp Leodolter; Sven-Eric Olsson; Grace W K Tang; Daron G Ferris; Jorma Paavonen; Marc Steben; F Xavier Bosch; Joakim Dillner; Warner K Huh; Elmar A Joura; Robert J Kurman; Slawomir Majewski; Evan R Myers; Luisa L Villa; Frank J Taddeo; Christine Roberts; Amha Tadesse; Janine T Bryan; Lisa C Lupinacci; Katherine E D Giacoletti; Heather L Sings; Margaret K James; Teresa M Hesley; Eliav Barr; Richard M Haupt
Journal:  J Natl Cancer Inst       Date:  2010-02-05       Impact factor: 13.506

6.  Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.

Authors:  Stan L Block; Terry Nolan; Carlos Sattler; Eliav Barr; Katherine E D Giacoletti; Colin D Marchant; Xavier Castellsagué; Steven A Rusche; Suzanne Lukac; Janine T Bryan; Paul F Cavanaugh; Keith S Reisinger
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

7.  Understanding the burden of human papillomavirus-associated anal cancers in the US.

Authors:  Djenaba A Joseph; Jacqueline W Miller; Xiaocheng Wu; Vivien W Chen; Cyllene R Morris; Marc T Goodman; Jose M Villalon-Gomez; Melanie A Williams; Rosemary D Cress
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

8.  Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials.

Authors:  Suzanne M Garland; Kevin A Ault; Stanley A Gall; Jorma Paavonen; Heather L Sings; Karen L Ciprero; Alfred Saah; Deborah Marino; Desmond Ryan; David Radley; Haiping Zhou; Richard M Haupt; Elizabeth I O Garner
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

9.  Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Authors:  J Paavonen; P Naud; J Salmerón; C M Wheeler; S-N Chow; D Apter; H Kitchener; X Castellsague; J C Teixeira; S R Skinner; J Hedrick; U Jaisamrarn; G Limson; S Garland; A Szarewski; B Romanowski; F Y Aoki; T F Schwarz; W A J Poppe; F X Bosch; D Jenkins; K Hardt; T Zahaf; D Descamps; F Struyf; M Lehtinen; G Dubin
Journal:  Lancet       Date:  2009-07-06       Impact factor: 79.321

10.  Male influences on cervical cancer risk.

Authors:  M V Zunzunegui; M C King; C F Coria; J Charlet
Journal:  Am J Epidemiol       Date:  1986-02       Impact factor: 4.897
View more
  6 in total

Review 1.  HPV Vaccination: An Underused Strategy for the Prevention of Cancer.

Authors:  Gilla K Shapiro
Journal:  Curr Oncol       Date:  2022-05-23       Impact factor: 3.109

2.  Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.

Authors:  Gedefaye Nibret Mihretie; Tewachew Muche Liyeh; Alemu Degu Ayele; Habtamu Gebrehana Belay; Tigist Seid Yimer; Agernesh Dereje Miskr
Journal:  Reprod Health       Date:  2022-06-10       Impact factor: 3.355

3.  Vaccines for adults: The time has come.

Authors:  I Gemmill
Journal:  Can Commun Dis Rep       Date:  2015-04-20

Review 4.  Safety of human papillomavirus vaccines: a review.

Authors:  Kristine K Macartney; Clayton Chiu; Melina Georgousakis; Julia M L Brotherton
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

5.  Evolution of Public Health Human Papillomavirus Immunization Programs in Canada.

Authors:  Alexandra Goyette; Glorian P Yen; Voica Racovitan; Parambir Bhangu; Smita Kothari; Eduardo L Franco
Journal:  Curr Oncol       Date:  2021-02-22       Impact factor: 3.677

6.  Anal Human Papillomavirus Prevalence Among Vaccinated and Unvaccinated Gay, Bisexual, and Other Men Who Have Sex With Men in Canada.

Authors:  Catharine Chambers; Shelley L Deeks; Rinku Sutradhar; Joseph Cox; Alexandra de Pokomandy; Troy Grennan; Trevor A Hart; Gilles Lambert; David M Moore; François Coutlée; Ann N Burchell
Journal:  Sex Transm Dis       Date:  2022-02-01       Impact factor: 2.830
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.